Posts

Showing posts from February, 2021

Bovine respiratory coronavirus enhances bacterial adherence by upregulating expression of cellular receptors on bovine respiratory epithelial cells - DocWire News

Image
Bovine respiratory coronavirus enhances bacterial adherence by upregulating expression of cellular receptors on bovine respiratory epithelial cells - DocWire News Bovine respiratory coronavirus enhances bacterial adherence by upregulating expression of cellular receptors on bovine respiratory epithelial cells - DocWire News Posted: 26 Feb 2021 10:00 PM PST This article was originally published here Vet Microbiol. 2021 Feb 17;255:109017. doi: 10.1016/j.vetmic.2021.109017. Online ahead of print. ABSTRACT Bovine coronavirus (BCoV) is one of the agents causing bovine respiratory disease complex (BRDC), with single infection tending to be mild to moderate; the probability of developing pneumonia in BRDC may be affected by viral and bacterial combinations. Previously, we reported that bovine respiratory syncytial virus (BRSV) infection enhances adherence of Pasteurella multocida (PM) to cells derived from the bovine lower respiratory t

A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study - The Lancet

A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study - The Lancet A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study - The Lancet Posted: 08 Feb 2021 12:00 AM PST [unable to retrieve full-text content] A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study    The Lancet You are subscribed to email updates from "respiratory drugs,respiratory failure causes,respiratory failure treatment" - Google News . To stop receiving these emails, you may unsubscribe now . Email delivery powered by Google Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States

Acute Respiratory Distress Syndrome (ARDS) Market Analysis, Size, Share, Growth 2020 Industry Driven - PharmiWeb.com

Image
Acute Respiratory Distress Syndrome (ARDS) Market Analysis, Size, Share, Growth 2020 Industry Driven - PharmiWeb.com Acute Respiratory Distress Syndrome (ARDS) Market Analysis, Size, Share, Growth 2020 Industry Driven - PharmiWeb.com Posted: 05 Feb 2021 12:00 AM PST Data Bridge Market Research report on Global Acute Respiratory Distress Syndrome (ARDS) Market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market's growth. Acute Respiratory Distress Syndrome (ARDS) market research report is a professional and a detailed report focusing on primary and secondary drivers, market share, size, growth, demand, leading segments and geographical analysis. The market research performed here also provides information about manufacturers, market competition, cost, market effect factors for the forecast period of 2020-2027. An excellent Acute R

“Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir - American Academy of Pediatrics” plus 1 more

Image
“Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir - American Academy of Pediatrics” plus 1 more Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir - American Academy of Pediatrics Posted: 01 Sep 2020 12:00 AM PDT During the coronavirus disease 2019 (COVID-19) pandemic, few children have been infected, and those affected have had a typically milder course than adults. 1 – 8 We describe an ex-premature infant who presented with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the fifth week of life. His clinical course differs from other reported pediatric cases showing only mild respiratory system involvement. 5 , 8 Severe respiratory distress developed in a short time frame, following severe airway compromise due to significant glottic swelling. Although his condition initially improved, severe acute respiratory distress syndrome (ARDS) developed a

“Lung mechanics and hypoxemia in COVID-19 patients with ARDS - News-Medical.Net” plus 1 more

Image
“Lung mechanics and hypoxemia in COVID-19 patients with ARDS - News-Medical.Net” plus 1 more Lung mechanics and hypoxemia in COVID-19 patients with ARDS - News-Medical.Net Posted: 31 Jan 2021 12:00 AM PST Researchers have created a dataset of COVID-19 patients with acute respiratory distress syndrome to help characterize lung compliance and hypoxemia, which may help administer better treatments. The severity of COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranges from no symptoms in some patients to severe disease, including death in others. Some patients require mechanical ventilation for respiratory failure and acute respiratory distress syndrome (ARDS). How COVID-19 related ARDS is different from other ARDS is still a subject of debate. Previous studies have small sample sizes and often do not have data on lung mechanics. To better understand how low blood oxygen level, or hypoxemia, a

Respiratory failure, clinical course and community management of COVID‐19 patients in a large Australian cohort - Wiley

Image
Respiratory failure, clinical course and community management of COVID‐19 patients in a large Australian cohort - Wiley Respiratory failure, clinical course and community management of COVID‐19 patients in a large Australian cohort - Wiley Posted: 25 Feb 2021 08:08 PM PST Introduction The current severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has resulted in unprecedented morbidity and mortality throughout the world. 1 Important risk factors associated with mortality includes advanced age, cardiorespiratory comorbidities, immunosuppression and diabetes mellitus. 2 , 3 The Sutherland Shire in New South Wales (NSW), Australia, has approximately 220 000 residents in 2016 National census. 4 It has a unique population with a higher proportion of those age 65 years and older, 4 85 years and older and coronary disease hospitalisations 5 compared to the rest of New South Wales. As such, when the first case of novel corona